Patents by Inventor Babak ALIPANAHI

Babak ALIPANAHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11887696
    Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: January 30, 2024
    Assignee: DEEP GENOMICS INCORPORATED
    Inventors: Brendan Frey, Michael K. K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
  • Publication number: 20220392639
    Abstract: A method for producing highly accurate, low cost phenotype labels for a cohort of individual using a machine learning model. The model is trained to predict phenotype labels from routine clinical data. We describe routine clinical data in the form of fundus images and making predictions as to phenotypes associated with eye diseases, such as glaucoma, however the methodology is more generally applicable to phenotype assignment from clinical data. The model is applied to a cohort of interest which includes both genomic data and the same type of routine clinical data. The model produces phenotype labels for each of the members of the cohort of interest. We then conduct a genetic association test (e.g., GWAS) on the cohort of interest using the phenotype labels produced by the model along with associated genomic data and identify genomic information (e.g., specific loci in the genome) associated with the phenotype.
    Type: Application
    Filed: October 13, 2020
    Publication date: December 8, 2022
    Inventors: Cory McLean, Babak Alipanahi, Justin Cosentino, Sonia Phene, Andrew Carroll
  • Publication number: 20210383890
    Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.
    Type: Application
    Filed: July 7, 2021
    Publication date: December 9, 2021
    Inventors: Brendan FREY, Michael K. K. LEUNG, Andrew Thomas DELONG, Hui Yuan XIONG, Babak ALIPANAHI, Leo J. LEE, Hannes BRETSCHNEIDER
  • Publication number: 20190252041
    Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.
    Type: Application
    Filed: November 20, 2018
    Publication date: August 15, 2019
    Inventors: Brendan Frey, Michael K.K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
  • Patent number: 10185803
    Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: January 22, 2019
    Assignee: DEEP GENOMICS INCORPORATED
    Inventors: Brendan Frey, Michael K. K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
  • Publication number: 20160364522
    Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.
    Type: Application
    Filed: June 15, 2015
    Publication date: December 15, 2016
    Inventors: Brendan FREY, Michael K.K. LEUNG, Andrew Thomas DELONG, Hui Yuan XIONG, Babak ALIPANAHI, Leo J. LEE, Hannes BRETSCHNEIDER